BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 62 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 3.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $866,040 | +8.3% | 122,322 | +7.7% | 0.01% | +16.7% |
| Q2 2023 | $799,435 | -25.4% | 113,556 | -11.7% | 0.01% | -33.3% |
| Q1 2023 | $1,072,232 | -32.5% | 128,565 | -7.1% | 0.01% | -35.7% |
| Q4 2022 | $1,587,959 | +20.0% | 138,324 | +31.7% | 0.01% | +16.7% |
| Q3 2022 | $1,323,000 | -3.6% | 104,999 | -19.1% | 0.01% | +9.1% |
| Q2 2022 | $1,373,000 | -24.7% | 129,723 | +15.8% | 0.01% | 0.0% |
| Q1 2022 | $1,823,000 | +5.3% | 112,030 | -10.4% | 0.01% | +22.2% |
| Q4 2021 | $1,732,000 | +788.2% | 125,095 | +822.3% | 0.01% | +800.0% |
| Q3 2021 | $195,000 | -93.9% | 13,564 | -94.9% | 0.00% | -87.5% |
| Q4 2014 | $3,222,000 | +44.0% | 264,963 | +15.8% | 0.01% | +60.0% |
| Q3 2014 | $2,237,000 | +559.9% | 228,740 | +760.2% | 0.01% | +400.0% |
| Q2 2014 | $339,000 | +34.0% | 26,591 | +11.2% | 0.00% | 0.0% |
| Q1 2014 | $253,000 | +88.8% | 23,919 | +35.8% | 0.00% | – |
| Q4 2013 | $134,000 | +10.7% | 17,610 | +6.3% | 0.00% | – |
| Q3 2013 | $121,000 | +290.3% | 16,565 | -17.3% | 0.00% | – |
| Q2 2013 | $31,000 | – | 20,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |